Nanomedicine is described as the use of nanoparticles to solve difficulties in medicine.
| Nanomedicines |
Nanomedicine is a branch of medicine that aims to use
nanotechnology—that is, the manipulation and fabrication of materials and
devices with a size of 1 to 100 nanometres (nm; 1 nm = 0.0000001 cm)—to prevent
disease and to image, diagnose, treat, repair, and regenerate biological
systems.
Despite the fact that Nanomedicine
is still in its infancy, a variety of nanomedical applications have been
created. The development of biosensors to aid in diagnostics and vehicles to
give vaccines, medicines, and genetic therapy, as well as the development of
nanocapsules to aid in cancer treatment, has been the focus of research thus
far.
Nanomaterials can be used in nanomedicine for diagnosis
(nanodiagnosis), controlled medication delivery (nanotherapy), and regenerative
medicine, among other things. Theranostics is a potential new field that
integrates diagnoses and therapy. It is a promising technique that holds both
the diagnosis/imaging agent and the drug in the same system.
Nanomedicine is bringing about positive changes in clinical
practise by introducing novel medicines for both diagnosis and treatment,
allowing us to address unmet medical needs by I integrating effective molecules
that would otherwise be unavailable due to their high toxicity (e.g., Mepact),
(ii) utilising multiple mechanisms of action (e.g., Nanomag, multifunctional
gels), and (iii) maximising efficacy (e.g., by increasing bioavailability) and
reducing dose and (iv) providing drug targeting, controlled and site specific
release, favoring a preferential distribution within the body (e.g., in areas
with cancer lesions) and improved transport across biological barriers.
Nanomedicine
is a branch of nanotechnology that has sparked interest as a location for
global study and development, giving the discipline academic and economic
validity. The United States, the United Kingdom, Germany, and Japan are the top
investors in nanomedicine research, with funding coming from both governmental
and commercial sources. China, France, India, Brazil, Russia, and India join
these countries in terms of nanomedicine research volume.
The size of molecules and biochemical processes, as well as
the scale on which nanomedicine operates (1 to 100 nm), provide much of its
rhetorical, technological, and scientific strength. The term nanomedicine
originally appeared in 1999, when American scientist Robert A. Freitas Jr.
published the first of two volumes on the subject, Nanomedicine: Basic
Capabilities.
Comments
Post a Comment